Fagan Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.18M | Sell |
|
|||||
|
2025
Q2 | $3.58M | Buy |
|
|||||
|
2025
Q1 | $3.2M | Buy |
|
|||||
|
2024
Q4 | $352K | Buy |
|
|||||
|
2024
Q3 | $296K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $256K | Hold |
|
|||||
|
2023
Q4 | $243K | Sell |
|
|||||
|
2023
Q3 | $278K | Hold |
|
|||||
|
2023
Q2 | $306K | Sell |
|
|||||
|
2023
Q1 | $337K | Hold |
|
|||||
|
2022
Q4 | $350K | Hold |
|
|||||
|
2022
Q3 | $346K | Hold |
|
|||||
|
2022
Q2 | $375K | Hold |
|
|||||
|
2022
Q1 | $355K | Hold |
|
|||||
|
2021
Q4 | $303K | Sell |
|
|||||
|
2021
Q3 | $3.52M | Buy |
|
|||||
|
2021
Q2 | $3.66M | Buy |
|
|||||
|
2021
Q1 | $3.43M | Buy |
|
|||||
|
2020
Q4 | $2.74M | Buy |
|
|||||
|
2020
Q3 | $2.64M | Buy |
|
|||||
|
2020
Q2 | $2.54M | Buy |
|
|||||
|
2020
Q1 | $1.64M | Buy |
|
|||||
|
2019
Q4 | $1.29M | Buy |
|
|||||
|
2019
Q3 | $368K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $206K | Sell |
|
|||||
|
2018
Q4 | $228K | Buy |
|
|||||
|
2018
Q3 | $244K | Sell |
|
|||||
|
2018
Q2 | $243K | Sell |
|
|||||
|
2018
Q1 | $447 | Sell |
|
|||||
|
2017
Q4 | $439 | Sell |
|
|||||
|
2017
Q3 | $503K | Hold |
|
|||||
|
2017
Q2 | $440K | Sell |
|
|||||
|
2017
Q1 | $448K | Buy |
|
|||||
|
2016
Q4 | $479K | Buy |
|